This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bohnsack, J F Articles by Hill, H R Search for Related Content PubMed PubMed Citation Articles by Bohnsack, J F Articles by Hill, H R

 Previous Article  |  Next Article 

Infect Immun. 1993 April; 61(4): 1421-1426

Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal species.

J F Bohnsack, J K Chang and H R Hill

Department of Pediatrics, University of Utah School of Medicine, Salt Lake City 84132.

ABSTRACT

Most strains of group B streptococci (GBS) elaborate a cell surface-associated enzyme that rapidly inactivates the human complement-derived chemoattractants C5a and C5adesarg by cleaving the His-Lys bond at positions 67 and 68 in the C5a molecule. We have suggested that rapid inactivation of C5a and C5adesarg by this enzyme, called C5a-ase, can hinder the inflammatory response at sites of GBS infection. We tested the ability of GBS C5a-ase to inactivate C5a preparations from various animal species to determine the proper species for studying the role of GBS C5a-ase in the pathogenesis of GBS infections. Exposure of C5a preparations from humans, monkeys, and cows to GBS caused inhibition of C5a functional activity as measured by the ability of C5a to stimulate human polymorphonuclear leukocyte (PMN) adherence and human PMN chemotaxis. Bovine PMN chemotaxis to bovine C5a was also abolished after exposure of bovine C5a to GBS. In contrast, mouse, rat, guinea pig, rabbit, pig, and sheep C5a preparations retained full functional activity after exposure to GBS as measured by chemotaxis of human PMNs, PMNs from the same animal species, or both. These data suggest that there are structural differences between C5a proteins from different species which alter their susceptibility to GBS C5a-ase and indicate that most commonly used animal models of human GBS infection are inadequate for detection of a contribution of GBS C5a-ase to GBS virulence.

---

Infect Immun. 1993 April; 61(4): 1421-1426

This article has been cited by other articles:

• Gleich-Theurer, U., Aymanns, S., Haas, G., Mauerer, S., Vogt, J., Spellerberg, B. (2009). Human Serum Induces Streptococcal C5a Peptidase Expression. Infect. Immun. 77: 3817-3825 [Abstract] [Full Text]  
• Lalioui, L., Pellegrini, E., Dramsi, S., Baptista, M., Bourgeois, N., Doucet-Populaire, F., Rusniok, C., Zouine, M., Glaser, P., Kunst, F., Poyart, C., Trieu-Cuot, P. (2005). The SrtA Sortase of Streptococcus agalactiae Is Required for Cell Wall Anchoring of Proteins Containing the LPXTG Motif, for Adhesion to Epithelial Cells, and for Colonization of the Mouse Intestine. Infect. Immun. 73: 3342-3350 [Abstract] [Full Text]  
• Lindahl, G., Stalhammar-Carlemalm, M., Areschoug, T. (2005). Surface Proteins of Streptococcus agalactiae and Related Proteins in Other Bacterial Pathogens. Clin. Microbiol. Rev. 18: 102-127 [Abstract] [Full Text]  
• Cheng, Q., Debol, S., Lam, H., Eby, R., Edwards, L., Matsuka, Y., Olmsted, S. B., Cleary, P. P. (2002). Immunization with C5a Peptidase or Peptidase-Type III Polysaccharide Conjugate Vaccines Enhances Clearance of Group B Streptococci from Lungs of Infected Mice. Infect. Immun. 70: 6409-6415 [Abstract] [Full Text]  
• Cheng, Q., Stafslien, D., Purushothaman, S. S., Cleary, P. (2002). The Group B Streptococcal C5a Peptidase Is Both a Specific Protease and an Invasin. Infect. Immun. 70: 2408-2413 [Abstract] [Full Text]  
• Veldkamp, K. E., Heezius, H. C. J. M., Verhoef, J., van Strijp, J. A. G., van Kessel, K. P. M. (2000). Modulation of Neutrophil Chemokine Receptors by Staphylococcus aureus Supernate. Infect. Immun. 68: 5908-5913 [Abstract] [Full Text]